| CTRI Number |
CTRI/2019/02/017516 [Registered on: 07/02/2019] Trial Registered Prospectively |
| Last Modified On: |
06/02/2019 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Behavioral |
| Study Design |
Other |
|
Public Title of Study
|
Role of Clinical Pharmacist in the healthcare management of Type II Diabetes mellitus patients |
|
Scientific Title of Study
|
Role of clinical pharmacist in holistic management of type II Diabetes Mellitus and patient satisfaction of care in medical OP |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Mrs S Sarumathy |
| Designation |
Assistant professor |
| Affiliation |
SRM Institute of Science and Technology |
| Address |
SRM Medical College Hospital and Research Centre
SRM Institute of Science and Technology (SRMIST)
Kattankulathur
Kancheepuram TAMIL NADU 603203 India |
| Phone |
9790535992 |
| Fax |
|
| Email |
saruprabakar@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr J S Kumar |
| Designation |
Professor, Department of General Medicine |
| Affiliation |
SRM Medical College Hospital and Research Centre |
| Address |
SRM Medical College Hospital and Research Centre
SRM Institute of Science and Technology (SRMIST)
Kattankulathur
Kancheepuram TAMIL NADU 603203 India |
| Phone |
9840047678 |
| Fax |
|
| Email |
drkumarjs@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr T M Vijayakumar |
| Designation |
Associate professor |
| Affiliation |
SRM Institute of Science and Technology |
| Address |
SRM Medical College Hospital and Research Centre
SRM Institute of Science and Technology (SRMIST)
Kattankulathur
Kancheepuram TAMIL NADU 603203 India |
| Phone |
9003400350 |
| Fax |
|
| Email |
vijaypractice@yahoo.com |
|
|
Source of Monetary or Material Support
|
| SRM Institute of Science and Technology |
|
|
Primary Sponsor
|
| Name |
NIL |
| Address |
NIL |
| Type of Sponsor |
Other [NIL] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| PAULIN C VARGHESE |
SRM Medical College Hospital and Research Centre |
Department of General Medicine Kancheepuram TAMIL NADU |
9600054755
angelopsr47@yahoo.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Proceeding of Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: E116||Type 2 diabetes mellitus with other specified complications, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Pharmacist counselling along with usual clinical care |
Pharmacist provides Patient Counselling on Medication Adherence and Assessment of patient satisfaction of care.At the baseline (during discharge) and at follow up (at 6 months) |
| Comparator Agent |
Usual Clinical Care |
Usual clinical care and assessment of patient satisfaction of care. At baseline (during discharge) and at follow up (At the end of six months) |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Both |
| Details |
Known case of Type II Diabetes patients who attended the OP department.
Patient whose HbA1C is ≥ 7
Patients of both genders >18 years of age
|
|
| ExclusionCriteria |
| Details |
Patients who are type 1 diabetes, gestational diabetes and psychiatric illness.
Patients who are not willing to participate in the study
|
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Other |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
Primary outcomes:
Assessment of patient satisfaction of care
Assessment of medication adherence by MARS scale
|
Measurement at Baseline visit and at the end of 3 months
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Secondary outcomes:
Improvement in laboratory parameters(Blood Pressure, Blood glucose, Lipid profile, S Creatinine)
Assesment of knowledge attitude and practice of diabetic patients at baseline and follow up.
To provide general education about diabetes.
|
Measurement at the baseline visit and at the end of 3 months |
|
|
Target Sample Size
|
Total Sample Size="200" Sample Size from India="200"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
11/02/2019 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
None yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
The term diabetes mellitus describes a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both. In 2017, there were 451 million (age 18-99 years) people with diabetes worldwide. It is predicted that by 2030 diabetes mellitus may afflict up to 79.4 million individuals in India, while China (42.3 million) and the United States (30.3 million) will also see significant increases in those affected by the disease. The total prevalence of diabetes in adults in India was 8.8 % in the year 2017. Intensive lifestyle interventions involving a combination of diet and physical activity can delay or prevent diabetes among people at high risk. Diabetes education and training is of critical importance and should be considered an integral part of diabetes prevention and care. Available literature suggests that the management of diabetes in India is sub-optimal for the majority of patients. Only 40–50% of individuals achieve the target for glycemic control, while lower numbers achieve targets for blood pressure and lipid control. Collaboration among physicians, nurses, dieticians, and pharmacists is required to ensure optimum patient care and adequate diabetes management. International standards for diabetes care have recognized the crucial role of pharmacists in diabetes management. There are lack of studies in India that analyze the attitudes and roles of pharmacist in diabetes management. The present study is an attempt in this direction. |